SlideShare a Scribd company logo
1 of 63
Download to read offline
knobbe.com
Intellectual Property for
Engineers
January 14, 2014
UC Irvine
2© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Overview
1. Background
2. Patent Quiz
3. Identifying IP
4. Protecting IP
5. Assessing 3rd Party Risk
6. Conclusions
©2012 Knobbe Martens, Olson & Bear, LLP all rights reserved.© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. 3
BACKGROUND
4© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Why have a patent system?
• First Patent Law – 1790
• Stimulate Innovation
• “Quid pro quo”
 Give full, public disclosure
 Receive exclusive rights
• Patents are just one form of “Intellectual Property”
 Intangible property rights
5© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Who cares?
• Inventors
• Employers
• Investors
• Entrepreneurs
Which is you?
6© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Benefits
• Often the most valuable assets of a start-up company.
– Can be critical to obtain financing/investment
• Allows idea sharing without risk of losing rights.
– Publish papers and demonstrate prototypes
• Protect Market
– Enforce rights to prevent unauthorized use.
• Injunction
• Damages ($)
• Source of revenue
• Defensive purposes
©2012 Knobbe Martens, Olson & Bear, LLP all rights reserved.© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. 7
PATENT QUIZ
8© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Patent Quiz – True or False?
• A patent application can be updated after it is filed to
incorporate new features.
• Liability for infringement can be avoided as long as
you don’t intend to infringe.
• Patent attorneys are always engineers or have some
technical background.
©2012 Knobbe Martens, Olson & Bear, LLP all rights reserved.© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. 9
IDENTIFYING IP
10© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Identifying Intellectual Property
• Patents - Right to exclude others from making, using, selling,
etc.; can help you obtain exclusivity in your market niche
(www.uspto.gov)
– Does not give patent owner right to make, use or sell
invention
• Commonly patented features:
– The device itself
– Key components
– Systems that include the device as well as other parts
– Method of manufacturing
– Method of using
– Materials (drugs, biologics, alloys, plastics, etc.)
11© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Identifying Intellectual Property
• Trademarks - Right to prevent use of marks that are
likely to confuse consumers; can greatly enhance
marketing strategies (www.uspto.gov)
• Copyrights - Right to prevent unauthorized copying,
distribution, etc. of authorship works
(www.copyright.gov)
• Trade Secrets - Protect internal methods, materials;
right to prevent unauthorized use (can protect against
use of proprietary information)
12© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Trademark Examples – Words and Names
13© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Trademark Examples – Designs and Logos
14© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Trademark Examples - Slogans
15© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Trademark Examples - Colors
“NEXIUM and the color purple as applied to the capsule are registered
trademarks of the AstraZeneca group of companies.”
16© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Where is the IP?
17© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Your Novel Idea – A Coated Stent
• Prior Art: Uncoated, bare metal stent
• Problem to Solve: Preventing restenosis
• Patentable Idea: Stent (100) having drug (or protein,
etc.) deposits 106 on metal struts (102) to inhibit
restenosis
Prior Art Your Invention
18© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Potential IP Protection
• A new drug eluting stent
– Patent – configuration of the drug eluting stent,
drug itself, method of depositing the drug on the
stent, method of deploying the stent in a body
– Trademark – product name – “Guardian Stent”
– Copyright – Instructions For Use, Product
Literature, Training Video, software
– Trade secret –method of manufacturing a kink-
resistant introducer sheath
19© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Patents vs. Trade Secrets
Patents
• Rights granted by U.S. Patent
& Trademark Office
• Expensive
• Rights last only 20 years
• Must fully disclose invention
• Right to exclude others from
practicing inventions
– Regardless of whether
copied or independently
derived
Trade Secrets
• Rights easily obtained
• Inexpensive
• Rights last as long as
information is maintained
confidential
• No public disclosure
• Right to prevent
misappropriation
– Can’t stop copiers or
independent derivation
20© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Patents vs. Trade Secrets – How to Choose
• Can invention be reverse engineered?
• What if secret is leaked?
• Will company seek private investment?
• Most technology is protected with patents.
21© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
2008 Berkeley Patent Survey
Percentage of Start-Up Companies
Holding U.S. Patents & Applications
39%
24%
82%
67%
76%75%
94%97%
0%
20%
40%
60%
80%
100%
All respondents Biotechnology Medical Devices Software/Internet
Overall population of companies (D&B) Venture-backed companies
Berkeley Technology Law Journal, vol. 24:4, pp. 1255-1328, April 16, 2010.
22© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
2008 Berkeley Patent Survey
Average Number of U.S. Patents & Applications
Held By Start-Up Companies
9.7
18.7
4.7
15
1.7
5.9
25.2
34.6
0
10
20
30
40
All respondents Biotechnology Medical Devices Software/Internet
Overall population of companies (D&B) Venture-backed companies
Berkeley Technology Law Journal, vol. 24:4, pp. 1255-1328, April 16, 2010.
23© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Patent Rights
• What right does a utility patent confer?
– The right to exclude others from making, using,
selling or importing the invention
– For 20 years from earliest filing date
• Patents do not provide a right to practice!
– Never say, “We don’t have any risk of getting sued
because we own the patent on our product.”
24© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Consider the Patented Improvement
Stent Nickel-
Titanium
Stent
Covered
Nickel-
Titanium
Stent
Drug Eluting,
Covered,
Nickel-Titanium
Stent
   
Patent
1
Patent
2
Patent
3
Your
Patent
©2012 Knobbe Martens, Olson & Bear, LLP all rights reserved.© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. 25
PROTECTING IP
26© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Protecting IP and Product Development
• Public Disclosure Can Prevent Patentability
– U.S. – One Year Grace Period
– Everywhere Else – Must File Beforehand
• Non-Disclosure Agreement
• Always better to file before disclosing
27© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Deadlines for Filing Patents
Public Disclosure Deadline to
File Patent Application
1 year
Public Disclosure
=
Deadline to
File Patent Application
U.S.
Rest of
World
28© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Protecting IP and Product Development
• First-to-Invent* vs. First-to-File
– U.S. changed to a
First-Inventor-to-File
system 3/16/2013
• Keep detailed lab notebooks
• Complete invention disclosure forms
• Save and date prototypes (or photographs)
29© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Requirements for Patentability
Invention as claimed must be
(a) Novel, and
(b)Non-obvious
with respect to the “prior art.”
Prior art includes earlier patents and printed publications
How do you know what is in the “prior art”?
30© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Searching – Why Bother?
• Searching is not required, but helps:
– Assess patentability
– Assess freedom-to-operate (risk)
– Identify key competitors
– Develop design arounds
31© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Searching Strategies
• Key word searching
– www.google.com/patents
– patft.uspto.gov
– www.delphion.com
– Key words – “coated stent
restenosis” or “drug eluting stent”
• Competitor / assignee
searching
• Journals / literature
• Hire a professional
32© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Contents of a Utility Patent
• Cover Page (title, abstract,
searching classification, prior art,
etc.)
• Figures
• Description
– The patent must be
written in full, clear, concise
terms to enable one of
ordinary skill in the art to
make or use the invention.
– The patent must describe
the best mode
contemplated by the
inventor for practicing the
invention (time of filing).
• Claims
33© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Claims
What is claimed is:
1. A drug eluting prosthesis, comprising:
a stent comprising an expandable substrate adapted for implantation in a
vessel of a body; and
a layer of drug eluting compound fixed to an outside surface of said
stent;
wherein:
said layer of drug eluting compound is uniformly deposited about the
outside surface of said stent.
2. The drug eluting prosthesis of Claim 1, wherein the expandable
substrate is made from a nickel-titanium alloy.
3. The drug eluting prosthesis of Claim 1, wherein the drug eluting
compound comprises a drug configured to prevent restenosis.
©2012 Knobbe Martens, Olson & Bear, LLP all rights reserved.© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. 34
ASSESSING 3RD PARTY RISK
35© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Survey Competitive Landscape
• Patents only provide a right to exclude,
not a right to practice
• How to identify possible risk:
– Searching
– Patent marking on competitor
products and labeling
– Receiving a letter from a competitor
• It is best to identify problem patents
early, before product design is frozen!
36© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Survey Competitive Landscape
• Who is likely to conduct initial risk
assessment?
YOU!
37© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Survey Competitive Landscape
• What can you do if you find a problem
patent?
– Design-around
– License
– Document internal analysis
– Opinion of counsel
(noninfringement, invalidity)
– Challenge the patent
– Wait
– Drop the project
38© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Reading Claims
• Assess risk of infringing competitor’s patents
• Claims consist of a series of limitations or elements
• All limitations (or, in some cases, equivalents thereof)
must be present for infringement
• All limitations must be performed or provided by the
same entity (with exceptions)
• Compare competitor’s patent’s claims to your product
39© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
How to Read a Claim
What is claimed is:
1. A drug eluting prosthesis,
comprising:
a stent comprising an expandable
substrate adapted for implantation in
a vessel of a body; and
a layer of drug eluting compound
fixed to an outside surface of said
stent;
wherein:
said layer of drug eluting compound
is uniformly deposited about the
outside surface of said stent.
Your Invention
Does your invention infringe Claim 1?
40© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
How to Read a Claim
What is claimed is:
1. A drug eluting prosthesis,
comprising:
a stent comprising an expandable
substrate adapted for implantation in
a vessel of a body; and
a layer of drug eluting compound
fixed to an outside surface of said
stent;
wherein:
said layer of drug eluting compound
is uniformly deposited about the
outside surface of said stent.
Your Invention
41© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
How to Read a Claim
What is claimed is:
1. A drug eluting prosthesis,
comprising:
a stent comprising an expandable
substrate adapted for implantation in
a vessel of a body; and
a layer of drug eluting compound
fixed to an outside surface of said
stent;
wherein:
said layer of drug eluting compound
is uniformly deposited about the
outside surface of said stent.
Your Invention
42© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
How to Read a Claim
What is claimed is:
1. A drug eluting prosthesis,
comprising:
a stent comprising an expandable
substrate adapted for implantation in
a vessel of a body; and
a layer of drug eluting compound
fixed to an outside surface of said
stent;
wherein:
said layer of drug eluting compound
is uniformly deposited about the
outside surface of said stent.
Your Invention
43© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
How to Read a Claim
What is claimed is:
1. A drug eluting prosthesis,
comprising:
a stent comprising an expandable
substrate adapted for implantation in
a vessel of a body; and
a layer of drug eluting compound
fixed to an outside surface of said
stent;
wherein:
said layer of drug eluting compound
is uniformly deposited about the
outside surface of said stent.
Your Invention
44© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
How to Read a Claim
What is claimed is:
1. A drug eluting prosthesis,
comprising:
a stent comprising an expandable
substrate adapted for implantation in
a vessel of a body; and
a layer of drug eluting compound
fixed to an outside surface of said
stent;
wherein:
said layer of drug eluting compound
is uniformly deposited about the
outside surface of said stent.
Your Invention
45© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
How to Read a Claim
What is claimed is:
1. A drug eluting prosthesis,
comprising:
a stent comprising an expandable
substrate adapted for implantation in
a vessel of a body; and
a layer of drug eluting compound
fixed to an outside surface of said
stent;
wherein:
said layer of drug eluting compound
is uniformly deposited about the
outside surface of said stent.
Your Invention
XTherefore, no literal infringement of Claim 1!
©2012 Knobbe Martens, Olson & Bear, LLP all rights reserved.© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. 46
CONCLUSIONS
47© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
What to Expect
• Maintain accurate and dated records of invention
• Use agreements when working with consultants and
contractors.
• File applications before making public disclosures
• Understand patent landscape and analyze risk early
• Your patent attorney can help!
© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. 48
49© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Inventor Notebooks
• Complete, sign and
witness everyday
• Fill in every page
• Attach drawings,
photos, data directly
to lab notebook page and sign
across borders
• Include things to try in the future
• Use care when
describing competitor
products or patents – what you
say could be used against you
later!
50© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Invention Disclosure Form
• Title
• Contributors
• Has invention been
disclosed outside of
the organization?
51© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
• Background
• Problem being
solved
• Known Prior Art
• Description of invention
• Include drawings,
photos, copies of
lab notebook,
engineering
drawings, flow charts
Invention Disclosure Form
52© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
• Advantages
• Why would invention
be important to
competitors?
• Possible
modifications and
additional uses
• Signature of contributors
and witnesses
Invention Disclosure Form
53© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Medical Device Claim Strategies
w Apparatus claims to protect the device or consumable
An endoluminal prosthesis for treating a diseased blood vessel,comprising: a
stent body having a plurality of struts and a plurality of openings between
said struts,said prosthesis having a restenosis inhibiting agent adhered
thereto.
w Claims to instrumentation used to deliver the device
A delivery device comprising an outer sheath,an inner core advanceable
relative to said outer sheath,and a lumen for receiving a guidewire
therein,wherein said inner core is configured to support a prosthesis
thereon.
w System claims for the combination of components
A system comprising: an endoluminal prosthesis having a restenosis
inhibiting agent adhered thereto; and a delivery device for delivering the
prosthesis to a deployment site within a medical patient.
54© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Medical Device Claim Strategies
w Method claims to protect how it’s used in the IFU
A method for repairing a portion of a diseased vascular tissue comprising:
advancing a delivery catheter to a diseased portion of a patient’s vasculature,
retracting an outer sheath of said delivery catheter,and expanding a
prosthesis against a vessel wall in said diseased portion.
w Method of manufacturing claims
A method for manufacturing a drug eluting stent,comprising: laser cutting a
hollow cylinder comprising Nitinol to form a plurality of struts and openings
in said hollow cylinder; depositing a restenosis inhibiting agent on one or
more of said plurality of struts.
55© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
How To Read A Claim
What is claimed is:
1. A method of treating a vascular occlusion, comprising:
i) applying a drug eluting coating to a stent;
ii) loading the stent onto a catheter;
iii) inserting the catheter into a patient’s vasculature;
iv) advancing the catheter to a vascular occlusion;
v) deploying the stent at the vascular occlusion; and
vi) removing the catheter from the patient’s vasculature.
Who infringes Claim 1?
56© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
How To Read A Claim
What is claimed is:
1. A method of treating a vascular occlusion, comprising:
i) applying a drug eluting coating to a stent;
ii) loading the stent onto a catheter;
iii) inserting the catheter into a patient’s vasculature;
iv) advancing the catheter to a vascular occlusion;
v) deploying the stent at the vascular occlusion; and
vi) removing the catheter from the patient’s vasculature.
Who infringes Claim 1?
57© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Joint Infringement
• Where actions are performed by separate entities, but
one entity acts under direction and control of the
other.
– Examples:
• Contractual obligation
• One entity acts as the agent of the other.
• May be very difficult to show Clinician and
Manufacturer are joint infringers.
• Divided infringement = no infringer
58© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
How To Read A Claim
What is claimed is:
1. A method of treating a vascular occlusion, comprising:
i) applying a drug eluting coating to a stent;
ii) loading the stent onto a catheter;
iii) inserting the catheter into a patient’s vasculature;
iv) advancing the catheter to a vascular occlusion;
v) deploying the stent at the vascular occlusion; and
vi) removing the catheter from the patient’s vasculature.
Divided Infringement
59© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
How To Read A Claim
What is claimed is:
1. A method of treating a vascular occlusion, comprising:
i) providing a catheter, the catheter having a stent mounted near
the catheter’s distal end;
ii) inserting the catheter into a patient’s vasculature;
iii) advancing the catheter to a vascular occlusion;
iv) deploying the stent at the vascular occlusion; and
v) removing the catheter from the patient’s vasculature.
Who infringes Claim 1?
60© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Direct vs. Indirect Infringement
• Direct Infringement
– Entity performing steps is the direct infringer.
– Clinicians may be shielded (pure medical
methods).
– Manufacturer generally preferred target.
• Indirect Infringement
– Does one entity provide a product that has no
substantial use except to infringe?
– Does one entity induce the other to infringe?
61© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
Indirect Infringement
• Contributory Infringement
– Are there substantial non-infringing uses for
product used to perform method?
• Inducement
– What is evidence that company knowingly induces
infringement with specific intent to infringe?
• User manuals, training materials, videos, web
sites, sales people, marketing materials
• Would method constitute an off-label use?
• Notify inducers to establish knowledge and
intent.
62© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved.
How To Read A Claim
What is claimed is:
1. A method of treating a vascular occlusion, comprising:
i) providing a catheter, the catheter having a stent mounted near
the catheter’s distal end;
ii) inserting the catheter into a patient’s vasculature;
iii) advancing the catheter to a vascular occlusion;
iv) deploying the stent at the vascular occlusion; and
v) removing the catheter from the patient’s vasculature.
Does Company induce Clinician to infringe?
knobbe.com
Orange County San Diego San Francisco Silicon Valley Los Angeles Seattle Washington DC
Andrew Douglas
andrew.douglas@knobbe.com
(949) 721-7623
Shannon Lam
shannon.lam@knobbe.com
(949) 721-6366

More Related Content

What's hot

Copy rights UNIT 2.pptx
Copy rights UNIT 2.pptxCopy rights UNIT 2.pptx
Copy rights UNIT 2.pptx
Lokeshc28
 

What's hot (20)

Intellectual property rights
Intellectual property rightsIntellectual property rights
Intellectual property rights
 
Copyright and IPR issues
Copyright and IPR issues   Copyright and IPR issues
Copyright and IPR issues
 
Impact of digital technology on intellectual property
Impact of digital technology on intellectual propertyImpact of digital technology on intellectual property
Impact of digital technology on intellectual property
 
Copyright ppt 1
Copyright ppt 1Copyright ppt 1
Copyright ppt 1
 
Copyright in india
Copyright in indiaCopyright in india
Copyright in india
 
Trademark Infringement,Types of Trademark Infringements and Remedies of Infri...
Trademark Infringement,Types of Trademark Infringements and Remedies of Infri...Trademark Infringement,Types of Trademark Infringements and Remedies of Infri...
Trademark Infringement,Types of Trademark Infringements and Remedies of Infri...
 
Copyright: Law of Copyrights and Infringement / A Presentation at NALSAR Hyde...
Copyright: Law of Copyrights and Infringement / A Presentation at NALSAR Hyde...Copyright: Law of Copyrights and Infringement / A Presentation at NALSAR Hyde...
Copyright: Law of Copyrights and Infringement / A Presentation at NALSAR Hyde...
 
A presentation on Copyright & Copyright Infringement
A presentation on Copyright & Copyright InfringementA presentation on Copyright & Copyright Infringement
A presentation on Copyright & Copyright Infringement
 
Introduction To Copyright Law
Introduction To Copyright LawIntroduction To Copyright Law
Introduction To Copyright Law
 
Deceptive similarity under trademark
Deceptive similarity under trademarkDeceptive similarity under trademark
Deceptive similarity under trademark
 
Intellectual Property Rights and its Types
Intellectual Property Rights and its TypesIntellectual Property Rights and its Types
Intellectual Property Rights and its Types
 
Enforcement Of Intellectual Property Rights Through Customs Vpd Final
Enforcement Of Intellectual Property Rights Through Customs Vpd FinalEnforcement Of Intellectual Property Rights Through Customs Vpd Final
Enforcement Of Intellectual Property Rights Through Customs Vpd Final
 
Infringement of trademark
Infringement of trademarkInfringement of trademark
Infringement of trademark
 
Trademark infringement and passing off remedies
Trademark infringement and passing off remediesTrademark infringement and passing off remedies
Trademark infringement and passing off remedies
 
Copyright Registration in India
Copyright Registration in IndiaCopyright Registration in India
Copyright Registration in India
 
intellectual property rights
intellectual property rightsintellectual property rights
intellectual property rights
 
Intellectual Property Rights (IPR)
Intellectual Property Rights (IPR)Intellectual Property Rights (IPR)
Intellectual Property Rights (IPR)
 
Trademark shraddha singhi
Trademark shraddha singhiTrademark shraddha singhi
Trademark shraddha singhi
 
A Report On The Patents Act, 1970 [Case Study : Apple Vs Samsung]
A Report On The Patents Act, 1970 [Case Study : Apple Vs Samsung]A Report On The Patents Act, 1970 [Case Study : Apple Vs Samsung]
A Report On The Patents Act, 1970 [Case Study : Apple Vs Samsung]
 
Copy rights UNIT 2.pptx
Copy rights UNIT 2.pptxCopy rights UNIT 2.pptx
Copy rights UNIT 2.pptx
 

Viewers also liked

leveraging Geographical Indications in Tamil Nadu
leveraging Geographical Indications in Tamil Naduleveraging Geographical Indications in Tamil Nadu
leveraging Geographical Indications in Tamil Nadu
IP Dome
 

Viewers also liked (20)

European Patent Office - general presentation
European Patent Office - general presentationEuropean Patent Office - general presentation
European Patent Office - general presentation
 
European and US Patent Law
European and US Patent LawEuropean and US Patent Law
European and US Patent Law
 
Best Patenting Strategies for Medical based Technologies | Patent Lawyer Exp...
 Best Patenting Strategies for Medical based Technologies | Patent Lawyer Exp... Best Patenting Strategies for Medical based Technologies | Patent Lawyer Exp...
Best Patenting Strategies for Medical based Technologies | Patent Lawyer Exp...
 
IP SMART Workbook : A Lab to Market Guide to Inventing for India
IP SMART Workbook : A Lab to Market Guide to Inventing for IndiaIP SMART Workbook : A Lab to Market Guide to Inventing for India
IP SMART Workbook : A Lab to Market Guide to Inventing for India
 
2014 Overview of USPTO Progams for Faster Examination
2014 Overview of USPTO Progams for Faster Examination 2014 Overview of USPTO Progams for Faster Examination
2014 Overview of USPTO Progams for Faster Examination
 
leveraging Geographical Indications in Tamil Nadu
leveraging Geographical Indications in Tamil Naduleveraging Geographical Indications in Tamil Nadu
leveraging Geographical Indications in Tamil Nadu
 
Lincoln on lawyering
Lincoln on lawyeringLincoln on lawyering
Lincoln on lawyering
 
Invention Spotting
Invention SpottingInvention Spotting
Invention Spotting
 
Software & Patenting: IP Outside Your Comfort Zone
Software & Patenting: IP Outside Your Comfort ZoneSoftware & Patenting: IP Outside Your Comfort Zone
Software & Patenting: IP Outside Your Comfort Zone
 
03-Brief Overview of U.S. Utility Patent Law and Practice
03-Brief Overview of U.S. Utility Patent Law and Practice03-Brief Overview of U.S. Utility Patent Law and Practice
03-Brief Overview of U.S. Utility Patent Law and Practice
 
04-Patentable Subject Matter 35 USC §101
04-Patentable Subject Matter 35 USC §10104-Patentable Subject Matter 35 USC §101
04-Patentable Subject Matter 35 USC §101
 
Software Patents
Software PatentsSoftware Patents
Software Patents
 
QR Codes & University Tech
QR Codes & University Tech QR Codes & University Tech
QR Codes & University Tech
 
Presentation on Software patenting in India
Presentation on Software patenting in IndiaPresentation on Software patenting in India
Presentation on Software patenting in India
 
Patents - NoCoBio Precision Medicine Summit July 2016
Patents - NoCoBio Precision Medicine Summit July 2016Patents - NoCoBio Precision Medicine Summit July 2016
Patents - NoCoBio Precision Medicine Summit July 2016
 
08-U.S. Patent Grant and Infringement Basics
08-U.S. Patent Grant and Infringement Basics08-U.S. Patent Grant and Infringement Basics
08-U.S. Patent Grant and Infringement Basics
 
Weh?
Weh?Weh?
Weh?
 
Smart Phone Apps, Policy Issues and Potential Pitfalls for University Technol...
Smart Phone Apps, Policy Issues and Potential Pitfalls for University Technol...Smart Phone Apps, Policy Issues and Potential Pitfalls for University Technol...
Smart Phone Apps, Policy Issues and Potential Pitfalls for University Technol...
 
10-The U.S. Patent Process: Filing to Disposition
10-The U.S. Patent Process: Filing to Disposition10-The U.S. Patent Process: Filing to Disposition
10-The U.S. Patent Process: Filing to Disposition
 
Ip in it
Ip in itIp in it
Ip in it
 

Similar to Intellectual Property for Engineers

Similar to Intellectual Property for Engineers (20)

Intellectual Property Considerations During Product Development
Intellectual Property Considerations During Product DevelopmentIntellectual Property Considerations During Product Development
Intellectual Property Considerations During Product Development
 
Introduction to IP: Basics of Patents, Trademarks, & Trade Secrets
Introduction to IP: Basics of Patents, Trademarks, & Trade SecretsIntroduction to IP: Basics of Patents, Trademarks, & Trade Secrets
Introduction to IP: Basics of Patents, Trademarks, & Trade Secrets
 
Why is Intellectual Property Important?
Why is Intellectual Property Important?Why is Intellectual Property Important?
Why is Intellectual Property Important?
 
Navigating the Patent Minefield
Navigating the Patent MinefieldNavigating the Patent Minefield
Navigating the Patent Minefield
 
Preparing Your Medical Device NewCo For IP Due Diligence
Preparing Your Medical Device NewCo For IP Due DiligencePreparing Your Medical Device NewCo For IP Due Diligence
Preparing Your Medical Device NewCo For IP Due Diligence
 
Preparing Your Medical Device NewCo For IP Due Diligence
Preparing Your Medical Device NewCo For IP Due DiligencePreparing Your Medical Device NewCo For IP Due Diligence
Preparing Your Medical Device NewCo For IP Due Diligence
 
Foley Hoag Patent Basics
Foley Hoag Patent BasicsFoley Hoag Patent Basics
Foley Hoag Patent Basics
 
Commercialization and Patent Infringement
Commercialization and Patent InfringementCommercialization and Patent Infringement
Commercialization and Patent Infringement
 
How to File for a Patent
How to File for a PatentHow to File for a Patent
How to File for a Patent
 
Design Patents
Design PatentsDesign Patents
Design Patents
 
Medical Device
Medical DeviceMedical Device
Medical Device
 
The Meaning of Patent Infringement and Patent Litigation
The Meaning of Patent Infringement and Patent LitigationThe Meaning of Patent Infringement and Patent Litigation
The Meaning of Patent Infringement and Patent Litigation
 
Competitive landsape by Clarivate Analytics
Competitive landsape by Clarivate AnalyticsCompetitive landsape by Clarivate Analytics
Competitive landsape by Clarivate Analytics
 
How to Avoid Losing Patent Rights
How to Avoid Losing Patent RightsHow to Avoid Losing Patent Rights
How to Avoid Losing Patent Rights
 
Monetizing Your Intellectual Property: Protecting Ideas that Generate Income
Monetizing Your Intellectual Property: Protecting Ideas that Generate IncomeMonetizing Your Intellectual Property: Protecting Ideas that Generate Income
Monetizing Your Intellectual Property: Protecting Ideas that Generate Income
 
Introduction to IP - Part 2: Some Basics of U.S. Patents
Introduction to IP - Part 2: Some Basics of U.S. PatentsIntroduction to IP - Part 2: Some Basics of U.S. Patents
Introduction to IP - Part 2: Some Basics of U.S. Patents
 
Traklight Webinar with Shane Olafson and Kyle Siegal on Patent Dos and Don'ts...
Traklight Webinar with Shane Olafson and Kyle Siegal on Patent Dos and Don'ts...Traklight Webinar with Shane Olafson and Kyle Siegal on Patent Dos and Don'ts...
Traklight Webinar with Shane Olafson and Kyle Siegal on Patent Dos and Don'ts...
 
Ip on a coffe break... be inventive... be creative... be free
Ip on a coffe break... be inventive... be creative... be freeIp on a coffe break... be inventive... be creative... be free
Ip on a coffe break... be inventive... be creative... be free
 
PATENT PROCTECTION
PATENT PROCTECTIONPATENT PROCTECTION
PATENT PROCTECTION
 
Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...
Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...
Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...
 

More from Knobbe Martens - Intellectual Property Law

More from Knobbe Martens - Intellectual Property Law (20)

Advanced Strategies for PTAB Practice: Focus on Petitioners
Advanced Strategies for PTAB Practice: Focus on PetitionersAdvanced Strategies for PTAB Practice: Focus on Petitioners
Advanced Strategies for PTAB Practice: Focus on Petitioners
 
Trademarks, the Metaverse, and NFTs, Oh My!
Trademarks, the Metaverse, and NFTs, Oh My!Trademarks, the Metaverse, and NFTs, Oh My!
Trademarks, the Metaverse, and NFTs, Oh My!
 
Intellectual Property Considerations for Designers & Artist
Intellectual Property Considerations for Designers & ArtistIntellectual Property Considerations for Designers & Artist
Intellectual Property Considerations for Designers & Artist
 
What You Should Know About Responding to IP Threats and Assertions - Knobbe M...
What You Should Know About Responding to IP Threats and Assertions - Knobbe M...What You Should Know About Responding to IP Threats and Assertions - Knobbe M...
What You Should Know About Responding to IP Threats and Assertions - Knobbe M...
 
What You Should Know About Responding to IP Threats and Assertions - Knobbe M...
What You Should Know About Responding to IP Threats and Assertions - Knobbe M...What You Should Know About Responding to IP Threats and Assertions - Knobbe M...
What You Should Know About Responding to IP Threats and Assertions - Knobbe M...
 
What You Should Know About Open-Source Software and Third-Party Vendors - Kno...
What You Should Know About Open-Source Software and Third-Party Vendors - Kno...What You Should Know About Open-Source Software and Third-Party Vendors - Kno...
What You Should Know About Open-Source Software and Third-Party Vendors - Kno...
 
Surfing the Waves of US IP Trends: Tips for Smoothly Riding the Waves in Writ...
Surfing the Waves of US IP Trends: Tips for Smoothly Riding the Waves in Writ...Surfing the Waves of US IP Trends: Tips for Smoothly Riding the Waves in Writ...
Surfing the Waves of US IP Trends: Tips for Smoothly Riding the Waves in Writ...
 
What You Should Know About Open-Source Software and Third-Party Vendors - Kno...
What You Should Know About Open-Source Software and Third-Party Vendors - Kno...What You Should Know About Open-Source Software and Third-Party Vendors - Kno...
What You Should Know About Open-Source Software and Third-Party Vendors - Kno...
 
What You Should Know About Data Privacy- Knobbe Martens Webinar Series for St...
What You Should Know About Data Privacy- Knobbe Martens Webinar Series for St...What You Should Know About Data Privacy- Knobbe Martens Webinar Series for St...
What You Should Know About Data Privacy- Knobbe Martens Webinar Series for St...
 
What You Should Know About Data Privacy- Knobbe Martens Webinar Series for St...
What You Should Know About Data Privacy- Knobbe Martens Webinar Series for St...What You Should Know About Data Privacy- Knobbe Martens Webinar Series for St...
What You Should Know About Data Privacy- Knobbe Martens Webinar Series for St...
 
Knobbe Practice Webinar Series: Strategic Considerations in Design Patent Fi...
 Knobbe Practice Webinar Series: Strategic Considerations in Design Patent Fi... Knobbe Practice Webinar Series: Strategic Considerations in Design Patent Fi...
Knobbe Practice Webinar Series: Strategic Considerations in Design Patent Fi...
 
What You Should Know About Trade Secrets - Knobbe Martens Webinar Series for ...
What You Should Know About Trade Secrets - Knobbe Martens Webinar Series for ...What You Should Know About Trade Secrets - Knobbe Martens Webinar Series for ...
What You Should Know About Trade Secrets - Knobbe Martens Webinar Series for ...
 
What You Should Know About Trade Secrets - Knobbe Martens Webinar Series for ...
What You Should Know About Trade Secrets - Knobbe Martens Webinar Series for ...What You Should Know About Trade Secrets - Knobbe Martens Webinar Series for ...
What You Should Know About Trade Secrets - Knobbe Martens Webinar Series for ...
 
Strategic Planning for Capturing and Protecting Intellectual Property - Knobb...
Strategic Planning for Capturing and Protecting Intellectual Property - Knobb...Strategic Planning for Capturing and Protecting Intellectual Property - Knobb...
Strategic Planning for Capturing and Protecting Intellectual Property - Knobb...
 
Knobbe Practice Webinar Series: Strategic Considerations for Claim Drafting –...
Knobbe Practice Webinar Series: Strategic Considerations for Claim Drafting –...Knobbe Practice Webinar Series: Strategic Considerations for Claim Drafting –...
Knobbe Practice Webinar Series: Strategic Considerations for Claim Drafting –...
 
Strategic Planning for Capturing and Protecting Intellectual Property - Knobb...
Strategic Planning for Capturing and Protecting Intellectual Property - Knobb...Strategic Planning for Capturing and Protecting Intellectual Property - Knobb...
Strategic Planning for Capturing and Protecting Intellectual Property - Knobb...
 
Part II - What You Should Know About Employment and Vendor Agreements – Part...
 Part II - What You Should Know About Employment and Vendor Agreements – Part... Part II - What You Should Know About Employment and Vendor Agreements – Part...
Part II - What You Should Know About Employment and Vendor Agreements – Part...
 
What You Should Know About Employment and Vendor Agreements - Knobbe Martens ...
What You Should Know About Employment and Vendor Agreements - Knobbe Martens ...What You Should Know About Employment and Vendor Agreements - Knobbe Martens ...
What You Should Know About Employment and Vendor Agreements - Knobbe Martens ...
 
Advanced Claiming Strategies for Artificial Intelligence/Machine Learning Inv...
Advanced Claiming Strategies for Artificial Intelligence/Machine Learning Inv...Advanced Claiming Strategies for Artificial Intelligence/Machine Learning Inv...
Advanced Claiming Strategies for Artificial Intelligence/Machine Learning Inv...
 
Part II - What You Should Know About Non-Disclosure Agreements - Knobbe Marte...
Part II - What You Should Know About Non-Disclosure Agreements - Knobbe Marte...Part II - What You Should Know About Non-Disclosure Agreements - Knobbe Marte...
Part II - What You Should Know About Non-Disclosure Agreements - Knobbe Marte...
 

Recently uploaded

COPYRIGHTS - PPT 01.12.2023 part- 2.pptx
COPYRIGHTS - PPT 01.12.2023 part- 2.pptxCOPYRIGHTS - PPT 01.12.2023 part- 2.pptx
COPYRIGHTS - PPT 01.12.2023 part- 2.pptx
RRR Chambers
 
Appeal and Revision in Income Tax Act.pdf
Appeal and Revision in Income Tax Act.pdfAppeal and Revision in Income Tax Act.pdf
Appeal and Revision in Income Tax Act.pdf
PoojaGadiya1
 
一比一原版(ECU毕业证书)埃迪斯科文大学毕业证如何办理
一比一原版(ECU毕业证书)埃迪斯科文大学毕业证如何办理一比一原版(ECU毕业证书)埃迪斯科文大学毕业证如何办理
一比一原版(ECU毕业证书)埃迪斯科文大学毕业证如何办理
Airst S
 
一比一原版赫尔大学毕业证如何办理
一比一原版赫尔大学毕业证如何办理一比一原版赫尔大学毕业证如何办理
一比一原版赫尔大学毕业证如何办理
Airst S
 
一比一原版曼彻斯特城市大学毕业证如何办理
一比一原版曼彻斯特城市大学毕业证如何办理一比一原版曼彻斯特城市大学毕业证如何办理
一比一原版曼彻斯特城市大学毕业证如何办理
Airst S
 
一比一原版埃克塞特大学毕业证如何办理
一比一原版埃克塞特大学毕业证如何办理一比一原版埃克塞特大学毕业证如何办理
一比一原版埃克塞特大学毕业证如何办理
Airst S
 
一比一原版伦敦南岸大学毕业证如何办理
一比一原版伦敦南岸大学毕业证如何办理一比一原版伦敦南岸大学毕业证如何办理
一比一原版伦敦南岸大学毕业证如何办理
Airst S
 

Recently uploaded (20)

3 Formation of Company.www.seribangash.com.ppt
3 Formation of Company.www.seribangash.com.ppt3 Formation of Company.www.seribangash.com.ppt
3 Formation of Company.www.seribangash.com.ppt
 
MOCK GENERAL MEETINGS (SS-2)- PPT- Part 2.pptx
MOCK GENERAL MEETINGS (SS-2)- PPT- Part 2.pptxMOCK GENERAL MEETINGS (SS-2)- PPT- Part 2.pptx
MOCK GENERAL MEETINGS (SS-2)- PPT- Part 2.pptx
 
COPYRIGHTS - PPT 01.12.2023 part- 2.pptx
COPYRIGHTS - PPT 01.12.2023 part- 2.pptxCOPYRIGHTS - PPT 01.12.2023 part- 2.pptx
COPYRIGHTS - PPT 01.12.2023 part- 2.pptx
 
Analysis of R V Kelkar's Criminal Procedure Code ppt- chapter 1 .pptx
Analysis of R V Kelkar's Criminal Procedure Code ppt- chapter 1 .pptxAnalysis of R V Kelkar's Criminal Procedure Code ppt- chapter 1 .pptx
Analysis of R V Kelkar's Criminal Procedure Code ppt- chapter 1 .pptx
 
Appeal and Revision in Income Tax Act.pdf
Appeal and Revision in Income Tax Act.pdfAppeal and Revision in Income Tax Act.pdf
Appeal and Revision in Income Tax Act.pdf
 
Hely-Hutchinson v. Brayhead Ltd .pdf
Hely-Hutchinson v. Brayhead Ltd         .pdfHely-Hutchinson v. Brayhead Ltd         .pdf
Hely-Hutchinson v. Brayhead Ltd .pdf
 
WhatsApp 📞 8448380779 ✅Call Girls In Nangli Wazidpur Sector 135 ( Noida)
WhatsApp 📞 8448380779 ✅Call Girls In Nangli Wazidpur Sector 135 ( Noida)WhatsApp 📞 8448380779 ✅Call Girls In Nangli Wazidpur Sector 135 ( Noida)
WhatsApp 📞 8448380779 ✅Call Girls In Nangli Wazidpur Sector 135 ( Noida)
 
一比一原版(ECU毕业证书)埃迪斯科文大学毕业证如何办理
一比一原版(ECU毕业证书)埃迪斯科文大学毕业证如何办理一比一原版(ECU毕业证书)埃迪斯科文大学毕业证如何办理
一比一原版(ECU毕业证书)埃迪斯科文大学毕业证如何办理
 
LITERAL RULE OF INTERPRETATION - PRIMARY RULE
LITERAL RULE OF INTERPRETATION - PRIMARY RULELITERAL RULE OF INTERPRETATION - PRIMARY RULE
LITERAL RULE OF INTERPRETATION - PRIMARY RULE
 
Andrea Hill Featured in Canadian Lawyer as SkyLaw Recognized as a Top Boutique
Andrea Hill Featured in Canadian Lawyer as SkyLaw Recognized as a Top BoutiqueAndrea Hill Featured in Canadian Lawyer as SkyLaw Recognized as a Top Boutique
Andrea Hill Featured in Canadian Lawyer as SkyLaw Recognized as a Top Boutique
 
8. SECURITY GUARD CREED, CODE OF CONDUCT, COPE.pptx
8. SECURITY GUARD CREED, CODE OF CONDUCT, COPE.pptx8. SECURITY GUARD CREED, CODE OF CONDUCT, COPE.pptx
8. SECURITY GUARD CREED, CODE OF CONDUCT, COPE.pptx
 
Shubh_Burden of proof_Indian Evidence Act.pptx
Shubh_Burden of proof_Indian Evidence Act.pptxShubh_Burden of proof_Indian Evidence Act.pptx
Shubh_Burden of proof_Indian Evidence Act.pptx
 
How do cyber crime lawyers in Mumbai collaborate with law enforcement agencie...
How do cyber crime lawyers in Mumbai collaborate with law enforcement agencie...How do cyber crime lawyers in Mumbai collaborate with law enforcement agencie...
How do cyber crime lawyers in Mumbai collaborate with law enforcement agencie...
 
一比一原版赫尔大学毕业证如何办理
一比一原版赫尔大学毕业证如何办理一比一原版赫尔大学毕业证如何办理
一比一原版赫尔大学毕业证如何办理
 
一比一原版曼彻斯特城市大学毕业证如何办理
一比一原版曼彻斯特城市大学毕业证如何办理一比一原版曼彻斯特城市大学毕业证如何办理
一比一原版曼彻斯特城市大学毕业证如何办理
 
A SHORT HISTORY OF LIBERTY'S PROGREE THROUGH HE EIGHTEENTH CENTURY
A SHORT HISTORY OF LIBERTY'S PROGREE THROUGH HE EIGHTEENTH CENTURYA SHORT HISTORY OF LIBERTY'S PROGREE THROUGH HE EIGHTEENTH CENTURY
A SHORT HISTORY OF LIBERTY'S PROGREE THROUGH HE EIGHTEENTH CENTURY
 
一比一原版埃克塞特大学毕业证如何办理
一比一原版埃克塞特大学毕业证如何办理一比一原版埃克塞特大学毕业证如何办理
一比一原版埃克塞特大学毕业证如何办理
 
CAFC Chronicles: Costly Tales of Claim Construction Fails
CAFC Chronicles: Costly Tales of Claim Construction FailsCAFC Chronicles: Costly Tales of Claim Construction Fails
CAFC Chronicles: Costly Tales of Claim Construction Fails
 
一比一原版伦敦南岸大学毕业证如何办理
一比一原版伦敦南岸大学毕业证如何办理一比一原版伦敦南岸大学毕业证如何办理
一比一原版伦敦南岸大学毕业证如何办理
 
Independent Call Girls Pune | 8005736733 Independent Escorts & Dating Escorts...
Independent Call Girls Pune | 8005736733 Independent Escorts & Dating Escorts...Independent Call Girls Pune | 8005736733 Independent Escorts & Dating Escorts...
Independent Call Girls Pune | 8005736733 Independent Escorts & Dating Escorts...
 

Intellectual Property for Engineers

  • 2. 2© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Overview 1. Background 2. Patent Quiz 3. Identifying IP 4. Protecting IP 5. Assessing 3rd Party Risk 6. Conclusions
  • 3. ©2012 Knobbe Martens, Olson & Bear, LLP all rights reserved.© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. 3 BACKGROUND
  • 4. 4© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Why have a patent system? • First Patent Law – 1790 • Stimulate Innovation • “Quid pro quo”  Give full, public disclosure  Receive exclusive rights • Patents are just one form of “Intellectual Property”  Intangible property rights
  • 5. 5© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Who cares? • Inventors • Employers • Investors • Entrepreneurs Which is you?
  • 6. 6© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Benefits • Often the most valuable assets of a start-up company. – Can be critical to obtain financing/investment • Allows idea sharing without risk of losing rights. – Publish papers and demonstrate prototypes • Protect Market – Enforce rights to prevent unauthorized use. • Injunction • Damages ($) • Source of revenue • Defensive purposes
  • 7. ©2012 Knobbe Martens, Olson & Bear, LLP all rights reserved.© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. 7 PATENT QUIZ
  • 8. 8© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Patent Quiz – True or False? • A patent application can be updated after it is filed to incorporate new features. • Liability for infringement can be avoided as long as you don’t intend to infringe. • Patent attorneys are always engineers or have some technical background.
  • 9. ©2012 Knobbe Martens, Olson & Bear, LLP all rights reserved.© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. 9 IDENTIFYING IP
  • 10. 10© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Identifying Intellectual Property • Patents - Right to exclude others from making, using, selling, etc.; can help you obtain exclusivity in your market niche (www.uspto.gov) – Does not give patent owner right to make, use or sell invention • Commonly patented features: – The device itself – Key components – Systems that include the device as well as other parts – Method of manufacturing – Method of using – Materials (drugs, biologics, alloys, plastics, etc.)
  • 11. 11© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Identifying Intellectual Property • Trademarks - Right to prevent use of marks that are likely to confuse consumers; can greatly enhance marketing strategies (www.uspto.gov) • Copyrights - Right to prevent unauthorized copying, distribution, etc. of authorship works (www.copyright.gov) • Trade Secrets - Protect internal methods, materials; right to prevent unauthorized use (can protect against use of proprietary information)
  • 12. 12© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Trademark Examples – Words and Names
  • 13. 13© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Trademark Examples – Designs and Logos
  • 14. 14© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Trademark Examples - Slogans
  • 15. 15© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Trademark Examples - Colors “NEXIUM and the color purple as applied to the capsule are registered trademarks of the AstraZeneca group of companies.”
  • 16. 16© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Where is the IP?
  • 17. 17© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Your Novel Idea – A Coated Stent • Prior Art: Uncoated, bare metal stent • Problem to Solve: Preventing restenosis • Patentable Idea: Stent (100) having drug (or protein, etc.) deposits 106 on metal struts (102) to inhibit restenosis Prior Art Your Invention
  • 18. 18© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Potential IP Protection • A new drug eluting stent – Patent – configuration of the drug eluting stent, drug itself, method of depositing the drug on the stent, method of deploying the stent in a body – Trademark – product name – “Guardian Stent” – Copyright – Instructions For Use, Product Literature, Training Video, software – Trade secret –method of manufacturing a kink- resistant introducer sheath
  • 19. 19© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Patents vs. Trade Secrets Patents • Rights granted by U.S. Patent & Trademark Office • Expensive • Rights last only 20 years • Must fully disclose invention • Right to exclude others from practicing inventions – Regardless of whether copied or independently derived Trade Secrets • Rights easily obtained • Inexpensive • Rights last as long as information is maintained confidential • No public disclosure • Right to prevent misappropriation – Can’t stop copiers or independent derivation
  • 20. 20© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Patents vs. Trade Secrets – How to Choose • Can invention be reverse engineered? • What if secret is leaked? • Will company seek private investment? • Most technology is protected with patents.
  • 21. 21© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. 2008 Berkeley Patent Survey Percentage of Start-Up Companies Holding U.S. Patents & Applications 39% 24% 82% 67% 76%75% 94%97% 0% 20% 40% 60% 80% 100% All respondents Biotechnology Medical Devices Software/Internet Overall population of companies (D&B) Venture-backed companies Berkeley Technology Law Journal, vol. 24:4, pp. 1255-1328, April 16, 2010.
  • 22. 22© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. 2008 Berkeley Patent Survey Average Number of U.S. Patents & Applications Held By Start-Up Companies 9.7 18.7 4.7 15 1.7 5.9 25.2 34.6 0 10 20 30 40 All respondents Biotechnology Medical Devices Software/Internet Overall population of companies (D&B) Venture-backed companies Berkeley Technology Law Journal, vol. 24:4, pp. 1255-1328, April 16, 2010.
  • 23. 23© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Patent Rights • What right does a utility patent confer? – The right to exclude others from making, using, selling or importing the invention – For 20 years from earliest filing date • Patents do not provide a right to practice! – Never say, “We don’t have any risk of getting sued because we own the patent on our product.”
  • 24. 24© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Consider the Patented Improvement Stent Nickel- Titanium Stent Covered Nickel- Titanium Stent Drug Eluting, Covered, Nickel-Titanium Stent     Patent 1 Patent 2 Patent 3 Your Patent
  • 25. ©2012 Knobbe Martens, Olson & Bear, LLP all rights reserved.© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. 25 PROTECTING IP
  • 26. 26© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Protecting IP and Product Development • Public Disclosure Can Prevent Patentability – U.S. – One Year Grace Period – Everywhere Else – Must File Beforehand • Non-Disclosure Agreement • Always better to file before disclosing
  • 27. 27© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Deadlines for Filing Patents Public Disclosure Deadline to File Patent Application 1 year Public Disclosure = Deadline to File Patent Application U.S. Rest of World
  • 28. 28© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Protecting IP and Product Development • First-to-Invent* vs. First-to-File – U.S. changed to a First-Inventor-to-File system 3/16/2013 • Keep detailed lab notebooks • Complete invention disclosure forms • Save and date prototypes (or photographs)
  • 29. 29© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Requirements for Patentability Invention as claimed must be (a) Novel, and (b)Non-obvious with respect to the “prior art.” Prior art includes earlier patents and printed publications How do you know what is in the “prior art”?
  • 30. 30© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Searching – Why Bother? • Searching is not required, but helps: – Assess patentability – Assess freedom-to-operate (risk) – Identify key competitors – Develop design arounds
  • 31. 31© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Searching Strategies • Key word searching – www.google.com/patents – patft.uspto.gov – www.delphion.com – Key words – “coated stent restenosis” or “drug eluting stent” • Competitor / assignee searching • Journals / literature • Hire a professional
  • 32. 32© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Contents of a Utility Patent • Cover Page (title, abstract, searching classification, prior art, etc.) • Figures • Description – The patent must be written in full, clear, concise terms to enable one of ordinary skill in the art to make or use the invention. – The patent must describe the best mode contemplated by the inventor for practicing the invention (time of filing). • Claims
  • 33. 33© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Claims What is claimed is: 1. A drug eluting prosthesis, comprising: a stent comprising an expandable substrate adapted for implantation in a vessel of a body; and a layer of drug eluting compound fixed to an outside surface of said stent; wherein: said layer of drug eluting compound is uniformly deposited about the outside surface of said stent. 2. The drug eluting prosthesis of Claim 1, wherein the expandable substrate is made from a nickel-titanium alloy. 3. The drug eluting prosthesis of Claim 1, wherein the drug eluting compound comprises a drug configured to prevent restenosis.
  • 34. ©2012 Knobbe Martens, Olson & Bear, LLP all rights reserved.© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. 34 ASSESSING 3RD PARTY RISK
  • 35. 35© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Survey Competitive Landscape • Patents only provide a right to exclude, not a right to practice • How to identify possible risk: – Searching – Patent marking on competitor products and labeling – Receiving a letter from a competitor • It is best to identify problem patents early, before product design is frozen!
  • 36. 36© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Survey Competitive Landscape • Who is likely to conduct initial risk assessment? YOU!
  • 37. 37© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Survey Competitive Landscape • What can you do if you find a problem patent? – Design-around – License – Document internal analysis – Opinion of counsel (noninfringement, invalidity) – Challenge the patent – Wait – Drop the project
  • 38. 38© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Reading Claims • Assess risk of infringing competitor’s patents • Claims consist of a series of limitations or elements • All limitations (or, in some cases, equivalents thereof) must be present for infringement • All limitations must be performed or provided by the same entity (with exceptions) • Compare competitor’s patent’s claims to your product
  • 39. 39© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. How to Read a Claim What is claimed is: 1. A drug eluting prosthesis, comprising: a stent comprising an expandable substrate adapted for implantation in a vessel of a body; and a layer of drug eluting compound fixed to an outside surface of said stent; wherein: said layer of drug eluting compound is uniformly deposited about the outside surface of said stent. Your Invention Does your invention infringe Claim 1?
  • 40. 40© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. How to Read a Claim What is claimed is: 1. A drug eluting prosthesis, comprising: a stent comprising an expandable substrate adapted for implantation in a vessel of a body; and a layer of drug eluting compound fixed to an outside surface of said stent; wherein: said layer of drug eluting compound is uniformly deposited about the outside surface of said stent. Your Invention
  • 41. 41© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. How to Read a Claim What is claimed is: 1. A drug eluting prosthesis, comprising: a stent comprising an expandable substrate adapted for implantation in a vessel of a body; and a layer of drug eluting compound fixed to an outside surface of said stent; wherein: said layer of drug eluting compound is uniformly deposited about the outside surface of said stent. Your Invention
  • 42. 42© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. How to Read a Claim What is claimed is: 1. A drug eluting prosthesis, comprising: a stent comprising an expandable substrate adapted for implantation in a vessel of a body; and a layer of drug eluting compound fixed to an outside surface of said stent; wherein: said layer of drug eluting compound is uniformly deposited about the outside surface of said stent. Your Invention
  • 43. 43© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. How to Read a Claim What is claimed is: 1. A drug eluting prosthesis, comprising: a stent comprising an expandable substrate adapted for implantation in a vessel of a body; and a layer of drug eluting compound fixed to an outside surface of said stent; wherein: said layer of drug eluting compound is uniformly deposited about the outside surface of said stent. Your Invention
  • 44. 44© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. How to Read a Claim What is claimed is: 1. A drug eluting prosthesis, comprising: a stent comprising an expandable substrate adapted for implantation in a vessel of a body; and a layer of drug eluting compound fixed to an outside surface of said stent; wherein: said layer of drug eluting compound is uniformly deposited about the outside surface of said stent. Your Invention
  • 45. 45© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. How to Read a Claim What is claimed is: 1. A drug eluting prosthesis, comprising: a stent comprising an expandable substrate adapted for implantation in a vessel of a body; and a layer of drug eluting compound fixed to an outside surface of said stent; wherein: said layer of drug eluting compound is uniformly deposited about the outside surface of said stent. Your Invention XTherefore, no literal infringement of Claim 1!
  • 46. ©2012 Knobbe Martens, Olson & Bear, LLP all rights reserved.© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. 46 CONCLUSIONS
  • 47. 47© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. What to Expect • Maintain accurate and dated records of invention • Use agreements when working with consultants and contractors. • File applications before making public disclosures • Understand patent landscape and analyze risk early • Your patent attorney can help!
  • 48. © 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. 48
  • 49. 49© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Inventor Notebooks • Complete, sign and witness everyday • Fill in every page • Attach drawings, photos, data directly to lab notebook page and sign across borders • Include things to try in the future • Use care when describing competitor products or patents – what you say could be used against you later!
  • 50. 50© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Invention Disclosure Form • Title • Contributors • Has invention been disclosed outside of the organization?
  • 51. 51© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. • Background • Problem being solved • Known Prior Art • Description of invention • Include drawings, photos, copies of lab notebook, engineering drawings, flow charts Invention Disclosure Form
  • 52. 52© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. • Advantages • Why would invention be important to competitors? • Possible modifications and additional uses • Signature of contributors and witnesses Invention Disclosure Form
  • 53. 53© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Medical Device Claim Strategies w Apparatus claims to protect the device or consumable An endoluminal prosthesis for treating a diseased blood vessel,comprising: a stent body having a plurality of struts and a plurality of openings between said struts,said prosthesis having a restenosis inhibiting agent adhered thereto. w Claims to instrumentation used to deliver the device A delivery device comprising an outer sheath,an inner core advanceable relative to said outer sheath,and a lumen for receiving a guidewire therein,wherein said inner core is configured to support a prosthesis thereon. w System claims for the combination of components A system comprising: an endoluminal prosthesis having a restenosis inhibiting agent adhered thereto; and a delivery device for delivering the prosthesis to a deployment site within a medical patient.
  • 54. 54© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Medical Device Claim Strategies w Method claims to protect how it’s used in the IFU A method for repairing a portion of a diseased vascular tissue comprising: advancing a delivery catheter to a diseased portion of a patient’s vasculature, retracting an outer sheath of said delivery catheter,and expanding a prosthesis against a vessel wall in said diseased portion. w Method of manufacturing claims A method for manufacturing a drug eluting stent,comprising: laser cutting a hollow cylinder comprising Nitinol to form a plurality of struts and openings in said hollow cylinder; depositing a restenosis inhibiting agent on one or more of said plurality of struts.
  • 55. 55© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. How To Read A Claim What is claimed is: 1. A method of treating a vascular occlusion, comprising: i) applying a drug eluting coating to a stent; ii) loading the stent onto a catheter; iii) inserting the catheter into a patient’s vasculature; iv) advancing the catheter to a vascular occlusion; v) deploying the stent at the vascular occlusion; and vi) removing the catheter from the patient’s vasculature. Who infringes Claim 1?
  • 56. 56© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. How To Read A Claim What is claimed is: 1. A method of treating a vascular occlusion, comprising: i) applying a drug eluting coating to a stent; ii) loading the stent onto a catheter; iii) inserting the catheter into a patient’s vasculature; iv) advancing the catheter to a vascular occlusion; v) deploying the stent at the vascular occlusion; and vi) removing the catheter from the patient’s vasculature. Who infringes Claim 1?
  • 57. 57© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Joint Infringement • Where actions are performed by separate entities, but one entity acts under direction and control of the other. – Examples: • Contractual obligation • One entity acts as the agent of the other. • May be very difficult to show Clinician and Manufacturer are joint infringers. • Divided infringement = no infringer
  • 58. 58© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. How To Read A Claim What is claimed is: 1. A method of treating a vascular occlusion, comprising: i) applying a drug eluting coating to a stent; ii) loading the stent onto a catheter; iii) inserting the catheter into a patient’s vasculature; iv) advancing the catheter to a vascular occlusion; v) deploying the stent at the vascular occlusion; and vi) removing the catheter from the patient’s vasculature. Divided Infringement
  • 59. 59© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. How To Read A Claim What is claimed is: 1. A method of treating a vascular occlusion, comprising: i) providing a catheter, the catheter having a stent mounted near the catheter’s distal end; ii) inserting the catheter into a patient’s vasculature; iii) advancing the catheter to a vascular occlusion; iv) deploying the stent at the vascular occlusion; and v) removing the catheter from the patient’s vasculature. Who infringes Claim 1?
  • 60. 60© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Direct vs. Indirect Infringement • Direct Infringement – Entity performing steps is the direct infringer. – Clinicians may be shielded (pure medical methods). – Manufacturer generally preferred target. • Indirect Infringement – Does one entity provide a product that has no substantial use except to infringe? – Does one entity induce the other to infringe?
  • 61. 61© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Indirect Infringement • Contributory Infringement – Are there substantial non-infringing uses for product used to perform method? • Inducement – What is evidence that company knowingly induces infringement with specific intent to infringe? • User manuals, training materials, videos, web sites, sales people, marketing materials • Would method constitute an off-label use? • Notify inducers to establish knowledge and intent.
  • 62. 62© 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. How To Read A Claim What is claimed is: 1. A method of treating a vascular occlusion, comprising: i) providing a catheter, the catheter having a stent mounted near the catheter’s distal end; ii) inserting the catheter into a patient’s vasculature; iii) advancing the catheter to a vascular occlusion; iv) deploying the stent at the vascular occlusion; and v) removing the catheter from the patient’s vasculature. Does Company induce Clinician to infringe?
  • 63. knobbe.com Orange County San Diego San Francisco Silicon Valley Los Angeles Seattle Washington DC Andrew Douglas andrew.douglas@knobbe.com (949) 721-7623 Shannon Lam shannon.lam@knobbe.com (949) 721-6366